Webinar Series: A Comprehensive Overview of Environmental Risk Assessment for Human Pharmaceuticals

This two-part webinar series introduces the tiered process of Environmental Risk Assessment (ERA) in Europe and compares it with the one used in the United States. We examine the different steps used from both a regulatory and technical perspective, and delve into what the proposed changes in ERA guidance from the European Medicines Agency (EMA) could mean for you.


Have a scheduling conflict?
Reserve your seat below to receive the on-demand presentations.
compliance and regulation binders stacked on top of each other